Ongoing In Vivo Studies with Cytoskeletal Drugs in Tau Transgenic Mice

E-ISSN： 1875-5828|3|3|215-219

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.3, Iss.3, 2006-07, pp. : 215-219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphorylated tau in neuritic plaques of APP^sw/Tau^vlw transgenic mice and Alzheimer disease

By Pérez Mar Morán María Ferrer Isidre Ávila Jesús Gómez-Ramos Pilar

Acta Neuropathologica, Vol. 116, Iss. 4, 2008-10 ,pp. : 409-418

Springer Publishing Company

Access to resources Recommend Favorite

In vivo stabilization of mutant human transthyretin in transgenic mice

By Tagoe Clement Reixach Natàlia Friske Linsey Mustra David French David Gallo Gloria Buxbaum Joel

Amyloid: The Journal of Protein Folding Disorders, Vol. 14, Iss. 3, 2007-01 ,pp. : 227-236

Informa Healthcare

Access to resources Recommend Favorite

Formation of Filamentous Tau Aggregations in Transgenic Mice Expressing V337M Human Tau

By Tanemura K. Akagi T. Murayama M. Kikuchi N. Murayama O. Hashikawa T. Yoshiike Y. Park J.-M. Matsuda K. Nakao S. Sun X. Sato S. Yamaguchi H. Takashima A.

Neurobiology of Disease, Vol. 8, Iss. 6, 2001-12 ,pp. : 1036-1045

Elsevier

Access to resources Recommend Favorite

FTDP-17 Mutations in tau Transgenic Mice Provoke Lysosomal Abnormalities and Tau Filaments in Forebrain

By Lim F. Hernández F. Lucas J.J. Gómez-Ramos P. Morán M.A. Ávila J.

Molecular and Cellular Neuroscience, Vol. 18, Iss. 6, 2001-12 ,pp. : 702-714

Academic Press

Access to resources Recommend Favorite

Hyperphosphorylated tau aggregates in the cortex and hippocampus of transgenic mice with mutant human FTDP-17 Tau and lacking the PARK2 gene

By Guerrero Rosa

Acta Neuropathologica, Vol. 117, Iss. 2, 2009-02 ,pp. : 159-168

Springer Publishing Company

Access to resources Recommend Favorite